Chemical Analysis Toxic Analysis Chemical Substance Property Information, Catalog of Supplier Manufacturer Distributor And Custom Synthesis Oganic Synthesis Bio-synthesis Companies For Raw Material Laboratory Reagent Equipment Solution Intermediate Specialty Chemicals And So On.

Search   

CAS Properties

MSDS  
: Compounds, Inorganic Platinum
CAS  :
SYNONYMS  : Compounds, Inorganic Platinum
Compounds, Platinum
D017671
Inorganic Platinum Compounds
Platinum Compounds
Platinum Compounds, Inorganic

  
MSDS LIST:
  • MSDS PAGE: CAS 15337-84-5 MSDS jmcatalysts_com---886.asp
    and Kligman dermal sensitization test gave a negative result. Users should note that if soluble ionic platinum-halogeno complexes are prepared from this material those complexes are likely to be allergenic. If sensitization to Platinum compounds occurs, all further exposure to ionic Platinum compounds must be prevented. 4. FIRST AID MEASURES Over-exposure may produce the following symptoms - First Aid Inhalation - irritating to the eyes, nose, throat and respiratory tract, producing coughing. Ingestion - nausea and vomiting. Eye contact - redness, irritation, blurred vision and pain. Skin - redness and irritation with possible tissue damage. First Aid - Inhalation remove from exposure and allow to rest in fresh air. Seek medical advice. rinse mouth with clean water and give water or milk to drink. Seek medical First Aid - Ingestion attention. irrigate with water or isotonic saline solution for 15 minutes. Seek medical First Aid - Eyes attention. remove contaminated clothing...
    http://www.chemcas.com/msds_archive/part2/cas/gq_msds/jmcatalysts_com---886.asp
  • MSDS PAGE: CAS 12325-31-4 MSDS jmcatalysts_com---473.asp
    halogeno compounds are prepared from this material, they will be highly allergenic. Persons with a history of allergic diseases should not be exposed to Platinum compounds. A history of cardiac or pulmonary disease may preclude exposure to Platinum compounds - medical opinion should be sought. Any person experiencing untoward effects or symptoms whilst using Platinum compounds should be removed from exposure and medically examined for Platinum sensitization. 4. FIRST AID MEASURES First Aid Over-exposure may produce the following symptoms - Inhalation - irritating to the eyes, nose, throat and respiratory tract, producing coughing. Ingestion - nausea and vomiting. Eye contact - redness, irritation, blurred vision and pain. Skin - redness and irritation with possible tissue damage. remove from exposure and allow to rest in fresh air. Seek medical advice. First Aid - Inhalation rinse mouth with clean water and give water or milk to drink. Seek medical First Aid - Ingestion...
    http://www.chemcas.com/msds_archive/part2/cas/gq_msds/jmcatalysts_com---473.asp
  • MSDS PAGE: CAS 38201-97-7 MSDS jmcatalysts_com---474.asp
    . This material is not thought to present a sensitization risk but, users should note that if ionic Platinum halogeno compounds are produced from it, they will probably be highly allergenic. Persons with a history of allergic diseases should not be exposed to Platinum compounds. A history of cardiac or pulmonary disease may preclude exposure to Platinum compounds - medical opinion should be sought. Any person experiencing untoward effects or symptoms whilst using Platinum compounds should be removed from exposure and medically examined for Platinum sensitivity. 4. FIRST AID MEASURES Over-exposure may produce the following symptoms - First Aid Inhalation - irritating to the eyes, nose, throat and respiratory tract, producing coughing. Ingestion - nausea and vomiting. Eye contact - redness, irritation, blurred vision and pain. Skin - redness and irritation with possible tissue damage. First Aid - Inhalation remove from exposure and allow to rest in fresh air. Seek medical...
    http://www.chemcas.com/msds_archive/part2/cas/gq_msds/jmcatalysts_com---474.asp
  • MSDS PAGE: CAS 123439-82-7 MSDS jmcatalysts_com---460.asp
    Platinum halogeno compounds are prepared from this material they will be highly allergenic. Persons with a history of allergic diseases should not be exposed to Platinum compounds. A history of cardiac or pulmonary diasease may preclude exposure to Platinum compounds - medical opinion should be sought. Any person experiencing untoward effects or symptoms whilst using Platinum compounds should be removed from exposure and medically examined for Platinum sensitization. 4. FIRST AID MEASURES Over-exposure may produce the following symptoms - First Aid Inhalation - irritating to the eyes, nose, throat and respiratory tract, producing coughing. Ingestion - nausea and vomiting. Eye contact - redness, irritation, blurred vision and pain. Skin - redness and irritation with possible tissue damage. First Aid - Inhalation remove from exposure and allow to rest in fresh air. Seek medical advice. rinse mouth with clean water and give water or milk to drink. Seek medical First Aid...
    http://www.chemcas.com/msds_archive/part2/cas/gq_msds/jmcatalysts_com---460.asp
  • MSDS PAGE: CAS N/A MSDS jmcatalysts_com---456.asp
    an allergenic (Type 1 sensitization) response and the solution is assumed to be similar. If this material is used to prepare other Platinum compounds, it should be noted that ionic Platinum-halogeno compounds are normally highly allergenic. 4. FIRST AID MEASURES First Aid Over-exposure may produce the following symptoms- Inhalation- Irritation of the respiratory tract. Eye contact- Redness and irritation. Skin contact- Irritation. Remove from exposure and allow to rest in fresh air. Seek medical advice if First Aid - Inhalation symptoms persist. Rinse mouth with clean water, give milk or water to drink. Seek medical First Aid - Ingestion advice if symptoms persist. Irrigate with clean water or isotonic saline solution for 15 minutes.Seek First Aid - Eyes medical advice if symptoms persist. Remove contaminated clothes and wash skin with soap and water. First Aid - Skin 5. FIRE FIGHTING MEASURES Although the material is not flammable, toxic fumes will be produced if involved in a fire...
    http://www.chemcas.com/msds_archive/part2/cas/gq_msds/jmcatalysts_com---456.asp
  • MSDS CAI-301 BRAZE TAPE molybdenum (soluble compound), lead molybdate tin (as sn) tungsten (insoluble), wolfram columbium, niobium *93-3* tantalum titanium (dry powder) (ti) manganese, mn compounds platinum cobalt trade secret component boron * 95-4 * nickel (suspected animal/human carcinogen by iarc group 2b, tin (as sn) trade secret component chromium metal, chromium, chrome (suspected a1 human iron copper (dust & mist), bronze powder CAS 7439-98-7 7440-31-5 7440-33-7 7440-03-1 7440-25-7 7440-32-6 7439-96-5 7440-06-4 7440-48-4 7440-42-8 7440-02-0 7440-31-5 7429-90-5 7440-47-3 7439-89-6 7440-50-8
    % name="CAI-301 BRAZE TAPE" cas="7439-98-7 7440-31-5 7440-33-7 7440-03-1 7440-25-7 7440-32-6 7439-96-5 7440-06-4 7440-48-4 7440-42-8 7440-02-0 7440-31-5 7429-90-5 7440-47-3 7439-89-6 MSDS   : CAI-301 BRAZE TAPE CAS   : 7439-98-7 7440-31-5 7440-33-7 7440-03-1 7440-25-7 7440-32-6 7439-96-5 7440-06-4 7440-48-4 7440-42-8 7440-02-0 7440-31-5 7429-90-5 7440-47-3 7439-89-6 7440-50-8 NAME   : molybdenum (soluble compound), lead molybdate tin (as sn) tungsten (insoluble), wolfram columbium, niobium *93-3* tantalum titanium (dry powder) (ti) manganese, mn compounds platinum cobalt trade secret component boron * 95-4 * nickel (suspected animal/human carcinogen by iarc group 2b, tin (as sn) trade secret component chromium metal, chromium, chrome (suspected a1 human iron copper (dust & mist), bronze powder ...
    http://www.chemcas.com/msds112/cas/2259/7439-98-7_7440-31-5_7440-33-7_7440-03-1_7440-50-8.asp
  • MSDS CAS# N/A gesswein_com_Platinum_Compounds_White_1500.asp
    MSDS Material Safety Data Sheet CAS N/A File Name : gesswein_com_Platinum_Compounds_White_1500.asp ...
    http://www.chemcas.org/msds_archive/msds_01/cas/gc_msds/gesswein_com_Platinum_Compounds_White_1500.asp
  • MSDS CAS# N/A espimetals_com_potassiumhexachloroplatinate.asp
    MSDS Material Safety Data Sheet CAS N/A File Name : espimetals_com_potassiumhexachloroplatinate.asp MATERIAL SAFETY DATA SHEET I PRODUCT IDENTIFICATION Trade Name: Potassium Hexachloroplatinate IV Formula: K2PtC16 II HAZARDOUS INGREDIENTS TLV (Units): 1.0 mg/m3 Ingredients: Potassium Hexachloroplatinate III PHYSICAL DATA 250 oC Melting Point: Solubility in H20: Slight Appearance and Odor: Yellow crystal powder IV FIRE AND EXPLOSION HAZARDS Flammability: Non-Flammable Extinguishing Media: C02 Special Fire Fighting Procedures: Self contained breathing apparatus Unusual Fire and Explosion Hazards: May emit toxic fumes upon decomposition V HEALTH HAZARD INFORMATION Effects of Overexposure: Platinum compounds may cause temporary symptoms in some individuals including; sneezing, conges- tion, wheezing, dermatitis, Etc... EMERGENCY AND FIRST AID PROCEDURES: INHALATION: Remove patient from area of exposure to fresh air. EYESs: Flush with eye bath. EXTERNAL: Flush with soap and water for 15...
    http://www.chemcas.org/msds_archive/msds_01/cas/gc_msds/espimetals_com_potassiumhexachloroplatinate.asp
  • Null
    ALL Chemical Analysis PAGES IN THIS GROUP NAME CAS gesswein_com_Opticon_Fracture_Seal_part_2.asp N/A gesswein_com_Orange_Flake_Shellac.asp N/A gesswein_com_Oxaul_Salts.asp N/A gesswein_com_OxiGuard_Step_1.asp N/A gesswein_com_OxiGuard_Step_2.asp N/A gesswein_com_Phosphoric_Acid.asp N/A gesswein_com_Pickling_Compound.asp N/A gesswein_com_Pink_Pen_Plating_Solution.asp N/A gesswein_com_Pink_Polishing_Wheels.asp N/A gesswein_com_Pitch.asp N/A gesswein_com_PlaceIt.asp N/A gesswein_com_PlastOWax.asp N/A gesswein_com_Plastic_Injection_Wax.asp N/A gesswein_com_Platinum_Binder_for_investment.asp N/A gesswein_com_Platinum_Blue_Compound.asp N/A gesswein_com_Platinum_Carrot_Compound.asp N/A gesswein_com_Platinum_Compounds_White_1500.asp N/A gesswein_com_Platinum_Injection_Wax.asp N/A gesswein_com_Platinum_Investment_plus.asp N/A gesswein_com_Platinum_Solder_medium_&_hard.asp N/A gesswein_com_Platinum_Tripoli_Compound.asp N/A gesswein_com_Polishers_Rubber_Points_green_brown_black.asp N/A gesswein...
    http://www.chemcas.org/msds_archive/msds_01/cas/gc_msds/idx_gp_173.asp
  • MSDS CAS# 16941-12-1 16941-12-1.asp
    will give symptoms of increasing severity and can eventually lead to chronic asthma. There is a risk of anaphylactic shock occuring in sensitised persons re-encountering platinum salts. Therefore, if sensitisation has developed, further exposure to platinum compounds must not be permitted. "Platinum asthma" is a prescribed occupational disease in the UK. Ingestion will lead to severe abdominal pain, with possible chemical burns to the mouth and throat. Contact with the skin will be irritating. Strong solutions are corrosive, with the possibility of burns in severe cases. Contact with the eyes will be painful at all levels of exposure. remove from exposure and allow to rest in fresh air. Rinse nose and mouth First Aid - Inhalation with clean water. If breathing is difficult, give oxygen if available. Get immediate medical attention. rinse mouth with water and give water or milk to drink. Do not induce First Aid - Ingestion vomiting. Get immediate medical attention. irrigate...
    http://www.chemcas.org/msds_archive/msds_01/cas/gb_msds/16941-12-1.asp
  • MSDS CAS# 16941-12-1 16941-12-1.asp
    will give symptoms of increasing severity and can eventually lead to chronic asthma. There is a risk of anaphylactic shock occuring in sensitised persons re-encountering platinum salts. Therefore, if sensitisation has developed, further exposure to platinum compounds must not be permitted. "Platinum asthma" is a prescribed occupational disease in the UK. Ingestion will lead to severe abdominal pain, with possible chemical burns to the mouth and throat. Contact with the skin will be irritating. Strong solutions are corrosive, with the possibility of burns in severe cases. Contact with the eyes will be painful at all levels of exposure. remove from exposure and allow to rest in fresh air. Rinse nose and mouth First Aid - Inhalation with clean water. If breathing is difficult, give oxygen if available. Get immediate medical attention. rinse mouth with water and give water or milk to drink. Do not induce First Aid - Ingestion vomiting. Get immediate medical attention. irrigate...
    http://www.chemcas.org/msds_archive/msds_01/cas/gc_msds/16941-12-1.asp
  • MSDS Potassium hexachloroplatinate(IV) CAS 16921-30-5 MSDS
    damage. May cause eye, skin, and respiratory tract irritation. May cause sensitization by inhalation and by skin contact. Corrosive to metal. Target Organs: Respiratory system, eyes, skin. Potential Health Effects Eye: May cause eye irritation. Risk of serious damage to eyes. Skin: May cause skin irritation. May be harmful if absorbed through the skin. May cause sensitization by skin contact. Ingestion: May cause irritation of the digestive tract. Poison by ingestion. Platinum compounds are generally highly toxic, even though the rate of absorption via the gastrointestinal tract is relatively poor. Symptoms of intoxication are hepatic and renal damage, impaired hearing, and severe sensitization with allergic manifestations in predisposed persons. Inhalation: May cause respiratory tract irritation. May be harmful if inhaled. May cause respiratory sensitization. Chronic: Repeated or prolonged exposure may cause allergic reactions in sensitive individuals. Section 4 - First Aid...
    http://www.chemcas.org/drug/analytical/cas/16921-30-5.asp
  • MSDS N/A
    : Heat may cause this product to decompose, destroy the product and produce irritating vapors and toxic gases. Store at temperatures not exceeding 25C. Do not refrigerate or freeze. Materials to avoid: This product is generally compatible with other common materials in a medical facility. Keep away from strong oxidizers and strong acids. Hazardous Decomposition Products: Carbon oxides, hydrogen chloride gas, nitrogen oxides. Hazardous Polymerisation: Will not occur Section 11. Toxicological Information Toxicity Information is for the Active Pharmaceutical ingredient: CISPLATIN Corrosivity/irritation (eye, skin, respiratory tract): This product is expected to be irritating to contaminated skin, eyes and other tissues. Sensitisation (skin, respiratory): Considered to be an allergen based on platinum compounds. Mutagenicity: In general, studies have produced positive (genotoxic) results. Cisplatin induced structural chromosomal aberrations and sister chromatid exchanges in cells of rodents...
    http://www.chemcas.org/msds114/supplier/cas/51/1650496719.asp
  • MSDS N/A
    : Heat may cause this product to decompose, destroy the product and produce irritating vapors and toxic gases. Store at temperatures not exceeding 25C. Do not refrigerate or freeze. Materials to avoid: This product is generally compatible with other common materials in a medical facility. Keep away from strong oxidizers and strong acids. Hazardous Decomposition Products: Carbon oxides, hydrogen chloride gas, nitrogen oxides. Hazardous Polymerisation: Will not occur Section 11. Toxicological Information Toxicity Information is for the Active Pharmaceutical ingredient: CISPLATIN Corrosivity/irritation (eye, skin, respiratory tract): This product is expected to be irritating to contaminated skin, eyes and other tissues. Sensitisation (skin, respiratory): Considered to be an allergen based on platinum compounds. Mutagenicity: In general, studies have produced positive (genotoxic) results. Cisplatin induced structural chromosomal aberrations and sister chromatid exchanges in cells of rodents...
    http://www.chemcas.org/msds114/supplier/cas/74/1650496719.asp
    ALL PAGES On Chemical Properties IN THIS GROUP
    NameCASSynonymsMolecular FormulaMolecular Weight
    EDO EDO
    NI NI
    SO4 SO4
    PLM PLM
    FMT FMT
    SAH SAH
    GOL GOL
    CL CL
    4MM 4MM
    IOD IOD
    SO4 SO4
    GOL GOL
    5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione
    C444919
    ES936 cpd
    Z-VAD peptide Z-VAD peptide
    benzyloxycarbonyl-valyl-alanyl-aspartic acid
    chlorinated dibenzofurans chlorinated dibenzofurans
    polychlorinated dibenzofurans
    Guggul Guggul
    Guggulu
    Gugulu
    Yogaraj-guggulu
    guggul extract
    guggul lipids
    guggulipid
    guggulu extract
    gugulipid
    gugulu extract
    gum guggulu
    4-isopropyl-3-(methylsulfonyl)benzoyl-guanidine methanesulfonate 4-isopropyl-3-(methylsulfonyl)benzoyl-guanidine methanesulfonate
    C093373
    HOE 642
    HOE-642
    HOE642
    cariporide
    Gd(III) texaphyrin Gd(III) texaphyrin
    PCI-0120
    Xcytrin
    gadolinium texaphyrin
    gadolinium texaphyrin complex
    motexafin gadolinium
    Compounds, Gold Compounds, Gold
    D017612
    Gold Compounds
    Dietary Fat Dietary Fat
    Dietary Fats
    Fat, Dietary
    Fats, Dietary
    Ghee
    Ghees
    EVAP protocol EVAP protocol
    15-deoxyprostaglandin J2 15-deoxyprostaglandin J2
    15d-PGJ2
    C477819
    1,3-bis(4-(phthalimidomethoxyimino-methyl)pyridinium-1-yl)propane dibromide 1,3-bis(4-(phthalimidomethoxyimino-methyl)pyridinium-1-yl)propane dibromide
    1,3-bis(4-(phthalimidomethoxyiminomethyl)pyridinium-1-yl)propane
    C420024
    WDuo3 cpd
    MEBCD cpd MEBCD cpd
    beta-MCD
    beta-methylcyclodextrin
    methyl beta-cyclodextrin
    methyl-beta-cyclodextrin
    Extracts, Plant Extracts, Plant
    Plant Extracts
    2,3,6,7-tetrachlorobiphenylene 2,3,6,7-tetrachlorobiphenylene
    C516412
    2'-deoxy-8-hydroxyguanosine 2'-deoxy-8-hydroxyguanosine
    8-OH-dG
    8-OHdG compound
    8-hydroxy-2'-deoxyguanosine
    8-hydroxydeoxyguanosine
    8-oxodGuo
    C040791
    Stanford V protocol Stanford V protocol
    Pesticides Pesticides
    3-(2-(2-hydroxyeth-1-yloxy)-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid 3-(2-(2-hydroxyeth-1-yloxy)-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid
    C098288
    SB 217242
    SB-217242
    enrasentan
    Compounds, Ferrous Compounds, Ferrous
    D005296
    Ferrous Compounds
    2,2',4,4',6-brominated diphenyl ether 2,2',4,4',6-brominated diphenyl ether
    BDE-100
    C517827
    pentabrominated diphenyl ether 100
    Compounds, Inorganic Platinum Compounds, Inorganic Platinum
    Compounds, Platinum
    D017671
    Inorganic Platinum Compounds
    Platinum Compounds
    Platinum Compounds, Inorganic
    Antigorite Antigorite
    Asbestos, Serpentine
    Asbestos, Serpentine, Chrysotile (Mg3(OH)4(Si2O5))
    Chrysotile
    D017632
    Serpentine (Mineral)
    Serpentine Asbestos
    1-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy) methyl)phenyl)sulfonyl)-N-(3-((4-(aminoimethyl) phenyl) carbonylamino)propyl)-2(S)-pyrrolidinecarboxamide 1-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy) methyl)phenyl)sulfonyl)-N-(3-((4-(aminoimethyl) phenyl) carbonylamino)propyl)-2(S)-pyrrolidinecarboxamide
    Anatibant
    C403051
    LF 16-0687
    LF16-0687
    LF16-0687Ms
    Oils, Plant Oils, Plant
    Oils, Vegetable
    Plant Oils
    Vegetable Oils
    2 Phenyl Benzopyran 4 Ones 2 Phenyl Benzopyran 4 Ones
    2-Phenyl-Benzopyran-4-Ones
    D044950
    Flavanones
    2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid 2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
    2-PPPE-IAA
    C483845
    PPEIA cpd
    Acids, Polyunsaturated Fatty Acids, Polyunsaturated Fatty
    Acids, Unsaturated Fatty
    D005231
    Fatty Acids, Polyunsaturated
    Fatty Acids, Unsaturated
    Polyunsaturated Fatty Acids
    Unsaturated Fatty Acids
    sirtinol sirtinol
    7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino(4,5-b)indole-1-acetamide 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino(4,5-b)indole-1-acetamide
    C456740
    SSR 180575
    SSR180575
    Fish Liver Oils Fish Liver Oils
    Fish Oils
    Liver Oils, Fish
    Oils, Fish
    Oils, Fish Liver
    (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine
    C516138
    compound C (Merck)
    dorsomorphin
    (3R,4S)-(+)-N-(3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl)-N-methylmethanesulfonamide (3R,4S)-(+)-N-(3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl)-N-methylmethanesulfonamide
    C420023
    HMR 1556
    chromanol HMR1556
    2,2',4,4'-brominated diphenyl ether 2,2',4,4'-brominated diphenyl ether
    BDE-47
    C517826
    tetrabrominated diphenyl ether 47
    alpha-zearalenol alpha-zearalenol
    alpha-zearalenol, (cis)-isomer
    beta-zearalenol
    zearalenol
    Chlorides, Vinylidene Chlorides, Vinylidene
    D004000
    Dichloroethylenes
    Vinylidene Chlorides
    Cytolysins Cytolysins
    Cytotoxic Agents
    Cytotoxins
    D003603
    MALP-2 MALP-2
    S-(2,3-bispalmitoyloxypropyl)-CGNNDESNISFKEK
    macrophage stimulatory lipopeptide 2
    Piperidines Piperidines



    HBCChem,Inc

    Chemical Information Net Copyright Reserved